Comorbidity Worsening under COVID-19 Infection

Available strictly for medical specialists.

Due to the significant increase of number of people infected with coronavirus and the fact that comorbid patients can be identified as the separate high-risk group, the Eurasian Association of Internal Medicine convokes experts in different fields to discuss possible patient management tactics.

COVID-19 and patients with comorbid pathology

The participation of six top experts in different areas:

• Grigorii Arutyunov – MD, PhD, Professor of Cardiology, President of the Eurasian Association of Internal Medicine, Corresponding Member of the Russian Academy of Sciences
• Alexander Arutyunov – MD, PhD, Professor of Internal Medicine, Secretary General of the Eurasian Association of Internal Medicine
• Sergei Zyrianov - MD, PhD, Professor, the Head of the Department of General and Clinical Pharmacology of the Peoples’ Friendship University of Russia
• Andrey Belevskii - MD, PhD, Professor of Pulmonology, Chief Specialist in Pulmonology of the Ministry of Healthcare of the Russian Federation
• Galina Kozhevnikova - MD, PhD, Professor, the Head of the Department of Infectious Diseases with Сourses of Epidemiology
• Olga Fedorova – MD, PhD, the Head of the Working Group “Endocrine Diseases” of the Eurasian Association of Internal Medicine.